Download full-text PDF

Source

Publication Analysis

Top Keywords

[subacute hepatitis
4
hepatitis fluminant
4
fluminant hepatitis]
4
[subacute
1
fluminant
1
hepatitis]
1

Similar Publications

Cholesterol ester storage disease (CESD) is a rare autosomal recessive lysosomal storage disorder caused by mutations in the LIPA gene, leading to reduced lysosomal acid lipase activity, cholesterol ester accumulation, and systemic manifestations including liver dysfunction and dyslipidemia. We report the case of a 25-year-old male presenting with subacute jaundice, hyperbilirubinemia (total bilirubin 51 mg/dL, predominantly direct), and dyslipidemia characterized by elevated total cholesterol and low HDL cholesterol levels. Initial diagnostic workup for acute hepatitis and liver dysfunction, including serological and imaging studies, was unremarkable.

View Article and Find Full Text PDF

Severe liver injury induced by minocycline in hepatitis B patient: a Case Report.

Front Pharmacol

December 2024

Pharmacy Department Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, Jiangsu Province, China.

Physical liver injury is an acute and potentially serious adverse event that may result in acute liver failure or even death. Diagnosis is often challenging. Minocycline, a semi-synthetic second-generation tetracycline, has high fat solubility and good tissue permeability.

View Article and Find Full Text PDF

The prognosis of patients with liver failure (LF) depends significantly on the etiology and clinical indicators. This analysis of these basic indicators can help provide a basis for the study of predictive outcome indicators. We collected the data from multiple centers in Southeast China, including subclasses of acute liver failure (ALF), subacute liver failure (SLF), acute-on-chronic liver failure (ACLF), subacute-on-chronic liver failure (SALF), and chronic liver failure (CLF).

View Article and Find Full Text PDF

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by enhancing the ability of the immune system to combat malignancies. Nivolumab and cemiplimab, monoclonal antibodies targeting programmed cell death protein 1, have exhibited notable therapeutic efficacy; however, they are associated with immune-related adverse events (irAEs). The present study describes the cases of 2 patients, a 71-year-old male with metastatic esophageal adenocarcinoma and a 66-year-old female with metastatic squamous cell carcinoma who developed acute/subacute onset rapidly progressive myositis/myasthenia gravis (MG) following treatment with nivolumab and cemiplimab.

View Article and Find Full Text PDF
Article Synopsis
  • Drug-induced liver injury (DILI), specifically anti-tuberculosis drug-induced liver injury (ATB-DILI), is a common side effect of tuberculosis treatment, prompting the Chinese Medical Association Tuberculosis Branch to create guidelines for better diagnosis and management.
  • These guidelines cover various topics, including risk factors (such as genetic variations and existing liver conditions), clinical classification, and comprehensive diagnostic procedures like blood tests and imaging.
  • Key recommendations include assessing liver function through specific biochemical tests, collecting detailed medical histories, and using liver biopsies for accurate diagnosis and prognosis of ATB-DILI.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!